← back to search

Douglas J. Hilton

Commonwealth Scientific and Industrial Research Organisation · AU
Area of research
Oncology · Immunology
Research interest
Research interests include Cytokine Signaling Pathways and Interactions, Immune Cell Function and Interaction, interferon and immune responses, and Platelet Disorders and Treatments.
h-index
93
citations
33,065
works
312
NIH funding
primary concept
email

Recent publications

The transcriptional co-repressor Runx1t1 is essential for MYCN-driven neuroblastoma tumorigenesis
Nature Communications 2024cited by 11position: middledoi
In vivo clonal tracking reveals evidence of haemangioblast and haematomesoblast contribution to yolk sac haematopoiesis.
2023cited by 30position: contributordoi
BAF complex-mediated chromatin relaxation is required for establishment of X chromosome inactivation.
2022cited by 15position: contributordoi
Chromosomes distribute randomly to, but not within, human neutrophil nuclear lobes.
2021cited by 13position: contributordoi
Proteomic analyses reveal that immune integrins are major targets for regulation by Membrane-Associated Ring-CH (MARCH) proteins MARCH2, 3, 4 and 9.
2021cited by 6position: contributordoi
Dissecting the molecular control of Interleukin 6 signaling using the M1 cell line.
2021cited by 2position: contributordoi
Membrane budding is a major mechanism of in vivo platelet biogenesis.
2020cited by 66position: contributordoi
Phylotranscriptomics resolves phylogeny of the Heliozelidae (Adeloidea: Lepidoptera) and suggests a Late Cretaceous origin in Australia
2020cited by 4position: contributordoi
Haemopedia RNA-seq: a database of gene expression during haematopoiesis in mice and humans.
2019cited by 139position: contributordoi
Membrane-associated RING-CH (MARCH) proteins down-regulate cell surface expression of the interleukin-6 receptor alpha chain (IL6Rα).
2019cited by 12position: contributordoi
The Pseudokinase MLKL Mediates Necroptosis via a Molecular Switch Mechanism
Immunity 2013cited by 1,204position: middledoi
The magnitude of acute hepatitis is more limited by regulation of cytokine signalling than apoptosis of liver-infiltrating effector CD8 T cells (P4174)
The Journal of Immunology 2013cited by 0position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Jeffrey J. Babon · Rockefeller University3 papers (2013–2021)Nicos A. Nicola · The University of Melbourne2 papers (2013–2019)Jian‐Guo Zhang · Hefei University of Technology2 papers (2013–2019)C. A. de Graaf · Oncode Institute2 papers (2021–2023)Shalin Naik · Saveetha University2 papers (2020–2023)Joanne M. Hildebrand · The University of Melbourne1 papers (2013–2013)Ian J. Majewski · The Netherlands Cancer Institute1 papers (2013–2013)Isabelle S. Lucet · Monash University1 papers (2013–2013)Rowena S. Lewis · Deakin University1 papers (2013–2013)Matthew E. Ritchie · Melbourne Health1 papers (2022–2022)Renwick C. J. Dobson · Biotechnology Institute1 papers (2013–2013)Patrick Bertolino · Royal Prince Alfred Hospital1 papers (2013–2013)Claire McGuffog · Royal Prince Alfred Hospital1 papers (2013–2013)James M. Murphy · The University of Melbourne1 papers (2013–2013)Jóse A. Villadangos · Biotechnology Institute1 papers (2019–2019)Lauren E. Holz · University of Massachusetts Amherst1 papers (2013–2013)Gillian M. Tannahill · GlaxoSmithKline (United Kingdom)1 papers (2013–2013)Leila N. Varghese · The University of Melbourne1 papers (2013–2013)Esme C. Hatchell · The University of Melbourne1 papers (2013–2013)Andreas Strasser · Medical University of Graz1 papers (2013–2013)